Insiders · Profile

Kewalramani Reshma

CEO & President at Vertex Pharmaceuticals. Filing since 8 Oct 2018. CIK 0001735944

Company

Date

Role

Action

Shares

Amount

Of holding

VRTX Vertex Pharmaceuticals

27 Feb 2026

CEO & President

Sold on a plan

40,000

$19.74M

28.9%

VRTX Vertex Pharmaceuticals

6 Aug 2025

CEO & President

Bought

10,000

$3.90M

9.4%

VRTX Vertex Pharmaceuticals

8 Nov 2024

CEO & President

Sold on a plan

15,198

$7.83M

16.7%

VRTX Vertex Pharmaceuticals

30 Jul 2024

CEO & President

Sold on a plan

15,202

$7.68M

14.3%

VRTX Vertex Pharmaceuticals

22 Jul 2024

CEO & President

Sold on a plan

15,202

$7.56M

12.5%

VRTX Vertex Pharmaceuticals

24 May 2024

CEO & President

Sold on a plan

1,565

$715.21K

1.3%

VRTX Vertex Pharmaceuticals

20 May 2024

CEO & President

Sold on a plan

15,202

$6.80M

11.1%

VRTX Vertex Pharmaceuticals

15 Dec 2023

CEO & President

Sold on a plan

17,135

$6.97M

13.6%

VRTX Vertex Pharmaceuticals

13 Dec 2023

CEO & President

Sold on a plan

5,098

$2.02M

4.5%

VRTX Vertex Pharmaceuticals

13 Nov 2023

CEO & President

Sold on a plan

5,097

$1.92M

4.3%

VRTX Vertex Pharmaceuticals

17 Jul 2023

CEO & President

Sold on a plan

7,828

$2.78M

6.2%

VRTX Vertex Pharmaceuticals

27 Apr 2023

CEO & President

Sold on a plan

3,317

$1.12M

2.6%

VRTX Vertex Pharmaceuticals

25 Jan 2023

CEO & President

Sold, plan not stated

10,000

$3.15M

10.0%

VRTX Vertex Pharmaceuticals

15 Aug 2022

CEO & President

Sold, plan not stated

11,689

$3.57M

10.5%

VRTX Vertex Pharmaceuticals

24 Jun 2022

CEO & President

Sold, plan not stated

11,689

$3.41M

9.5%

VRTX Vertex Pharmaceuticals

19 Aug 2021

CEO & President

Bought

10,000

$1.96M

15.7%

VRTX Vertex Pharmaceuticals

6 Aug 2020

CEO & President

Sold, plan not stated

2,073

$562.20K

7.2%

VRTX Vertex Pharmaceuticals

15 May 2020

CEO & President

Sold, plan not stated

99

$28.13K

0.4%

VRTX Vertex Pharmaceuticals

6 May 2020

CEO & President

Sold, plan not stated

2,074

$565.88K

7.2%

VRTX Vertex Pharmaceuticals

25 Feb 2020

EVP and CMO

Sold, plan not stated

3,634

$848.37K

12.0%

VRTX Vertex Pharmaceuticals

18 Feb 2020

EVP and CMO

Sold, plan not stated

1,183

$288.07K

3.4%

VRTX Vertex Pharmaceuticals

6 Feb 2020

EVP and CMO

Sold, plan not stated

2,074

$496.60K

5.6%

VRTX Vertex Pharmaceuticals

25 Nov 2019

EVP and CMO

Sold, plan not stated

4,692

$1.03M

26.4%

VRTX Vertex Pharmaceuticals

15 Nov 2019

EVP and CMO

Sold, plan not stated

61

$12.56K

0.5%

VRTX Vertex Pharmaceuticals

8 Nov 2019

EVP and CMO

Sold, plan not stated

509

$101.29K

3.7%

VRTX Vertex Pharmaceuticals

30 Oct 2019

EVP and CMO

Sold, plan not stated

3,057

$608.34K

18.9%

VRTX Vertex Pharmaceuticals

22 Oct 2019

EVP and CMO

Sold, plan not stated

638

$120.58K

4.6%

VRTX Vertex Pharmaceuticals

15 May 2019

EVP and CMO

Sold, plan not stated

241

$39.86K

1.7%

VRTX Vertex Pharmaceuticals

19 Feb 2019

EVP and CMO

Sold, plan not stated

1,488

$278.16K

9.8%

VRTX Vertex Pharmaceuticals

8 Oct 2018

EVP and CMO

Sold, plan not stated

2,305

$430.92K

54.7%

30 decisions on file.